Arno Therapeutics Inc

(ARNI)

By |

Profile

Arno Therapeutics Inc operates as a biopharmaceutical company. It develops drug candidates to treat patients with cancer and other life-threatening diseases. It develops pre-clinical and clinical-stage product under the following name: Onapristone, AR-42, and AR-12. Onapristone is indicated for endometrial, prostate and breast cancer indications, AR-42 is provided for hematological malignancies and solid tumors indications and AR-12 is offered for solid tumors and hematological malignancies, and various anti-microbial targets.

Contact Information

Website: www.arnothera.com
Email: info@arnothera.com
Main Phone: +1 862 703-7170
Address: 200 Route 31 North
Address 2: Suite 104
State: NJ
City / Town: Flemington
Country: USA
Postal Code: 08822

Issuer Information

Exchange: OTO
CEO: Glenn Mattes
Employees: 4
NAICS: Biological Product (except Diagnostic) Manufacturing(325414)
$ 0.0027 $ 0. (0.00%)
Last Price 0.0027 Change $ 0. Change % 0.00 Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close 0.0027
Last Trade Volume 0 52 Wk Hi 0.06 52 Wk Low 0.0005
Market Cap 133,244 Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 49,349,749.00 EPS (TTM) -0.43 PE Ratio N/A Exchange OTCPK